Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis.
Maretbayeva SM, Rakisheva AS, Adenov MM, Yeraliyeva LT, Algozhin YZ, Stambekova AT, Berikova EA, Yedilbayev A, Rich ML, Seung KJ, Issayeva AM. Maretbayeva SM, et al. Among authors: rich ml. Int J Infect Dis. 2021 Dec;113 Suppl 1:S91-S95. doi: 10.1016/j.ijid.2021.03.075. Epub 2021 Apr 3. Int J Infect Dis. 2021. PMID: 33823277 Free article.
Programmes and principles in treatment of multidrug-resistant tuberculosis.
Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, Bayona J, Farmer P, Smith Fawzi MC, Seung KJ. Mukherjee JS, et al. Among authors: rich ml. Lancet. 2004 Feb 7;363(9407):474-81. doi: 10.1016/S0140-6736(04)15496-2. Lancet. 2004. PMID: 14962530 Review.
Number of drugs to treat multidrug-resistant tuberculosis.
Seung KJ, Joseph K, Hurtado R, Rich M, Shin S, Furin J, Leandre F, Mukherjee J, Farmer P. Seung KJ, et al. Am J Respir Crit Care Med. 2004 Jun 15;169(12):1336-7; author reply 1337. doi: 10.1164/ajrccm.169.12.965. Am J Respir Crit Care Med. 2004. PMID: 15187016 No abstract available.
Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.
Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Nikiforov M, Yedilbayev A, Mukherjee JS, Furin JJ, Barry DJ, Farmer PE, Rich ML, Keshavjee S. Shin SS, et al. Among authors: rich ml. Int J Tuberc Lung Dis. 2006 Apr;10(4):402-8. Int J Tuberc Lung Dis. 2006. PMID: 16602404
Multidrug-resistant tuberculosis management in resource-limited settings.
Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC. Nathanson E, et al. Among authors: rich ml. Emerg Infect Dis. 2006 Sep;12(9):1389-97. doi: 10.3201/eid1209.051618. Emerg Infect Dis. 2006. PMID: 17073088 Free PMC article.
94 results